Dar Al-Shifa Pharmaceuticals Company reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was USD 17.15 million compared to USD 12.98 million a year ago. Net income was USD 3.08 million compared to USD 0.965539 million a year ago. Basic earnings per share from continuing operations was USD 0.36 compared to USD 0.11 a year ago.